Moment Partners’s Novartis NVS Stock Holding History

Moment Partners’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,365	Closed	-$209K	–	112
2026 Q1	$209K	Buy	+1,365	New	+$209K	0.04%	111

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Moment Partners's NVS Position: Q2 2026 in Review

Moment Partners sold out of Novartis (NVS) in Q2 2026, closing a stake of 1,365 shares — an estimated $209K sold.

Moment Partners first reported a position in NVS in Q1 2026 and held it in 1 quarter. The position peaked at $209K in Q1 2026. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Moment Partners reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
Moment Partners sold 1,365 Novartis shares in Q2 2026, an estimated $209K.
Moment Partners first reported a position in Novartis in Q1 2026 and held it in 1 quarter.
Moment Partners's Novartis position peaked at $209K in Q1 2026.
1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Moment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.